Using non-hypothesized based approaches for biomarker development
Using non-hypothesized based approaches for biomarker development
Jessica Gill, PhD, RN, FAAN, Bloomberg Distinguished Professor at Johns Hopkins School of Nursing, presents research on a highly multiplexed proteomic technique that used a DNA aptamers assay to target 1,305 proteins in plasma samples from athletes with and without a sports-related concussion (SRC). Researchers identified 338 plasma proteins significantly differed in abundance in concussed athletes compared to non-concussed athletes.
Learning objectives
- Understand current limits of protein quantification
- Describe ways to improve biomarker identification and measurement related to brain injuries
- Determine ways to address current limitations to personalized medicine approaches for brain injuries
Jessica Gill, PhD, RN, FAAN
Bloomberg Distinguished Professor
Johns Hopkins School of Nursing
Jessica Gill is a national leader in research on the biological mechanisms of traumatic brain injuries (TBI). She has spent decades investigating differential responses in military personnel, athletes, and other patients that have experienced TBIs and the mechanisms underlying these divergent responses. Specifically, Dr. Gill looks for ways to use biomarkers to identify which patients are at high risk for poor recovery and long-term effects including post-traumatic stress disorder, depression, and post-concussive syndrome, and to develop treatments.
After earning her PhD at JHSON, she went to the National Institutes of Health (NIH) to complete a postdoctoral fellowship at the National Institute of Nursing Research that focused on the biological mechanisms of PTSD and depression. At NIH, she also served as a senior investigator and acting deputy scientific director of the National Institute of Nursing Research and deputy director of the Center for Neuroscience and Regenerative Medicine. Dr. Gill was the first nurse to receive the Lasker Clinical Research Scholar Award, considered the most prestigious research grant given by the NIH. As Bloomberg Distinguished Professor of Trauma Recovery Biomarkers, she will hold primary appointments in the Johns Hopkins School of Nursing and the School of Medicine, Department of Neurology.
Using non-hypothesized based approaches for biomarker development
A presentation by Jessica Gill, PhD, RN, FAAN
More webinars
WebinarLinking the plasma proteome to echocardiographic parameters in patients with chronic heart failure
Recent advancements in proteomic profiling have unlocked new possibilities for understanding the complex mechanisms that drive heart failure. Measuring thousands of proteins simultaneously makes it possible to capture a comprehensive overview of the patient's health state and investigate underlying disease progression at a subclinical level.
WebinarB Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC
In this webinar, Gary Middleton, MD, PhD, and Akshay Patel, PhD, from the University of Birmingham explore the role of the B cell repertoire and autoantibodies in shaping responses to checkpoint blockade immunotherapy in non-small-cell lung cancer (NSCLC). They demonstrate how autoantibody profiling using the i-Ome™ Discovery protein microarray revealed biomarkers predictive of treatment efficacy and immune-related adverse events (irAEs), providing insights into biomarker development and personalized immunotherapy strategies.
WebinarSerum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched healthy controls.